Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Mar 15;16(3):e0248536. doi: 10.1371/journal.pone.0248536

Rapid detection of extended spectrum β-lactamase producing Escherichia coli isolated from fresh pork meat and pig cecum samples using multiplex recombinase polymerase amplification and lateral flow strip analysis

Sitthichai Kanokudom 1, Thachaporn Assawakongkarat 1,#, Yukihiro Akeda 2,3,#, Panan Ratthawongjirakul 1,#, Rungtip Chuanchuen 4,#, Nuntaree Chaichanawongsaroj 1,*
Editor: Iddya Karunasagar5
PMCID: PMC7959403  PMID: 33720963

Abstract

The emergence and dissemination of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli is a global health issue. Food-producing animals, including pigs, are significant reservoirs of antimicrobial resistance (AMR), which can be transmitted to humans. Thus, the rapid detection of ESBLs is required for efficient epidemiological control and treatment. In this study, multiplex recombinase polymerase amplification (RPA) combined with a single-stranded tag hybridization chromatographic printed-array strip (STH-PAS), as a lateral flow strip assay (LFA), was established for the rapid and simultaneous detection of multiple bla genes in a single reaction. Visible blue lines, indicating the presence of the blaCTX-M, blaSHV, and blaOXA genes, were observed within 10 min by the naked eye. The limit of detection of all three genes was 2.5 ng/25 μL, and no cross-reactivity with seven commensal aerobic bacteria was observed. A total of 93.9% (92/98) and 96% (48/50) of the E. coli isolates from pork meat and fecal samples, respectively, expressed an ESBL-producing phenotype. Nucleotide sequencing of the PCR amplicons showed that blaCTX-M was the most prevalent type (91.3–95.83%), of which the main form was blaCTX-M-55. The sensitivity and specificity of the RPA-LFA were 99.2% and 100%, respectively, and were in almost perfect agreement (κ = 0.949–1.000) with the results from PCR sequencing. Thus, the RPA-LFA is a promising tool for rapid and equipment-free ESBL detection and may facilitate clinical diagnosis in human and veterinary medicine, as well as AMR monitoring and surveillance.

Introduction

The rising level of antimicrobial resistance (AMR) worldwide has a significant impact on humans, animals, and the environment. One of the major reservoirs of AMR organisms and determinants is food animals, especially pigs and poultry, due to the overuse/misuse of antibiotics in farms to prevent and reduce the risk of infection [1]. Apart from antibiotic residues in food, antibiotic resistance genes can disseminate from animals to animals and animals to humans via the food chain [2]. Escherichia coli, a part of the commensal flora in human and animal intestines, acts as a fecal index of food hygiene, and simultaneously represents the carriage of AMR [36].

Extended spectrum β-lactamase (ESBL)-producing E. coli have been categorized by the World Health Organization (WHO) as being the most critical AMR pathogen to human health and a major public health concern. The incidence of ESBL-producing E. coli has increased globally in hospitals and livestock [79]. Broad-spectrum β-lactamase enzymes hydrolyze penicillins, cephalosporins (first-, second- and third-generation), and aztreonam but not carbapenems. However, these enzymes are inhibited by clavulanate [10]. In Thailand, a previous study has reported that the prevalence of ESBL-producing E. coli in the food industries and in animal farmworkers, pigs, fresh pig meat (pork), and water sources from pig farms ranges from 61.5–77.3%, which is higher than that in fresh vegetables, fish and cooked foods, as well as in canals and shrimp ponds [11]. Up to 86% of bacterial isolates (97.8% E. coli) from food animals, including pigs, cattle, chicken, and sheep, produce CTX-M group 1 [2]. Recently, up to 92% of CTX-M groups have been detected among the multidrug-resistant (MDR) E. coli isolates from healthy finisher and breeder pigs and boot swabs from pig farms [12].

According to the Clinical and Laboratory Standards Institute (CLSI), phenotypic screening and confirmation is the standard method for ESBL detection. However, the method is laborious, time-consuming, and unable to discriminate between different ESBL genotypes. In addition, the low expression level and coexistence of more than one AMR gene, especially in different drug classes, may confer false susceptibility or resistance results [13, 14]. Several molecular techniques have been used to detect the presence of ESBL genes, including PCR, real-time PCR, microarray, and next-generation sequencing [1517], but most of these techniques require expensive instruments and well-trained personnel to operate and analyze the results.

Recombinase polymerase amplification (RPA), first introduced in 2006, has been applied in various fields, particularly for the diagnosis of infectious diseases. RPA is simple to perform and uses a single low temperature of 37–42°C with two primers. The double-stranded DNA template is dissociated by a recombinase and single-stranded binding protein, and then, Sau DNA polymerase generates new complementary products within 5–20 min [18]. The results of alternative post-RPA detection methods using SYBR Green or a lateral flow strip assay (LFA) are easily observed by the naked eye, and can be applied for point-of-care testing and field studies [1921]. Hence, this study attempted to develop multiplex RPA combined with LFA to detect the three most common ESBL genes (blaCTX-M, blaOXA, and blaSHV). ESBL-producing E. coli was obtained from pork collected from retailed markets in Bangkok, Thailand, and pig cecum samples from a wholesale slaughterhouse. Each antibiotic susceptibility profile was examined by disk diffusion, and ESBL variants were characterized by nucleotide sequencing and the RPA-LFA.

Materials and methods

Sample collection

A total of 100 pork samples (200 g each) were randomly purchased from one vendor each from 100 fresh markets in Bangkok, Thailand, from June to December 2019. Samples were collected, kept on ice, and transported to the laboratory for analysis within 24 h. Fifty pig cecum samples were obtained from a wholesale slaughterhouse in Suphanburi Province, Thailand, in February 2020. The history of antibiotic administration to the pigs was unknown. All samples were kept at 4°C until processed.

Isolation of ESBL-producing E. coli

Each pork meat sample was gently chopped into small pieces, and then, 25 g of chopped pork was added to 225 mL of sterile peptone water and incubated at 37°C overnight. One loop of the peptone culture was streaked onto MacConkey agar (Oxoid, UK) supplemented with 1 g/L cefotaxime (Oxoid, UK). Fecal material from cecum samples from each pig was collected using a sterile cotton swab and directly inoculated on MacConkey agar supplemented with 1 g/L cefotaxime. Three typical lactose fermented (LF) colonies were randomly selected from each sample, screened for E. coli on eosin methylene blue agar (Oxoid, UK), and identified by conventional biochemical testing, including MIO, TSI, LIA, citrate, and urea utilization [22]. If all the isolates from the same sample were designated as E. coli by the same biochemical results, then a single isolate was randomly selected.

All the selected E. coli isolates were subsequently confirmed by PCR amplification of UspA using E. coli-specific primers (Table 1). PCR included 0.05 μM of each primer, 200 μM dNTPs, 0.625 U Taq polymerase (NEB, Inc., USA), and 50 ng DNA template in a total volume of 25 μL. The PCR amplification conditions were as follows: 94°C for 5 min, 35 cycles of 94°C for 30 sec, 60°C for 15 sec, 72°C for 30 sec, and 72°C for 5 min.

Table 1. Primer sequences and their product sizes.

Target gene Primer sequence (5’ to 3’) Amplicon size (bp) Reference
uspA F–AATGCAGGCTACCCAATCAC 162 This study
R–GGTGTTGATCAGCTGACGTG
blaCTX-M F–ATGTGCAGYACCAGTAARGTKATGGC 593 [23]
R–TGGGTRAARTARGTSACCAGAAYCAGCGG
blaTEM F–TCCGCTCATGAGACAATAACC 931 [24]
R–TTGGTCTGACAGTTACCAATGC
blaSHV F–TGGTTATGCGTTATATTCGCCC 868 [25]
R–GGTTAGCGTTGCCAGTGCT
blaOXA F–ACACAATACATATCAACTTCGC 814 [26]
R–AGTGTGTGTTTAGAATGGTGATC
blaCTX-M-tag F–Biotin–ATGTGCAGYACCAGTAARGTKATGGC 593 This study
R–tag1–TGGGTRAARTARGTSACCAGAAYCAGCGG
blaSHV-tag F–tag2–GATGAACGCTTTCCCATGATG 214 This study
R–Biotin–CGCTGTTATCGCTCATGGTAA
blaOXA-tag F–Biotin–ATTATCTACAGCAGCGCCAGTG 296 This study
R–tag3–TGCATCCACGTCTTTGGTG

Antimicrobial susceptibility testing

The susceptibility to 21 antimicrobial agents (ampicillin, cefpodoxime, ceftriaxone, cefepime, cefotaxime, ceftazidime, aztreonam, amoxicillin-clavulanate, piperacillin-tazobactam, imipenem, meropenem, amikacin, gentamycin, kanamycin, streptomycin, ciprofloxacin, nalidixic acid, tetracycline, trimethoprim-sulfamethoxazole, azithromycin and chloramphenicol) was determined using the disk diffusion method. The production of ESBL was detected by the combination disk method as recommended by CLSI [27]. E. coli ATCC 25922 was used as a quality control strain.

Characterization of ESBL genes by PCR-sequencing

Four common ESBL genes (blaCTX-M, blaOXA, blaSHV, and blaTEM) were screened in all the bacterial isolates by PCR and confirmed by DNA sequencing. Each obtained sequence was subsequently compared to known genotype sequences in the NCBI database using the BLASTn program. In brief, whole-cell DNA from the bacterial isolates was prepared by the boiling method. PCR was subsequently performed using gene-specific primers (Table 1). Each PCR was composed of 0.2 μM of each primer, 200 μM dNTPs, 0.625 U Taq polymerase (NEB Inc., USA), and 50 ng DNA template in a total volume of 25 μL. PCR amplification was performed at an initial temperature of 94°C for 5 min followed by 35 cycles of 94°C for 30 sec, 60°C for 15 sec, and 72°C for 30 sec and then a final 72°C for 5 min. The PCR products were analyzed by 1.5% (w/v) agarose gel electrophoresis and submitted for commercial nucleotide sequencing analysis (Bioneer Corporation, South Korea).

Multiplex RPA-LFA

A TwistDx basic kit (TwistDx, UK) was used for the amplification of the blaCTX-M, blaOXA, and blaSHV genes according to the manufacturer’s instructions. The sequences of the specific tag-primers used in the RPA reactions are shown in Table 1. The positive DNA controls, E. coli EC 137 (harboring blaCTX-M and blaOXA) and Klebsiella pneumoniae KP 125 (harboring blaSHV), were kindly provided by Prof. Dr. Visanu Thamlikitkul, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. In brief, the RPA-LFA conditions were optimized for a uniplex reaction (0.2 μM blaSHV tag primers) and multiplex reactions of two (0.24 μM of blaCTX-M and 0.06 μM blaOXA tag primers) and three primer sets (0.2 μM blaSHV, 0.2 μM of blaCTX-M and 0.1 μM blaOXA tag primers). Each primer set was mixed with 29.5 μL rehydration buffer, a freeze-dried protein pellet, 1 μL of 50 ng DNA template, and 1.25 μL of 280 mM magnesium acetate in a final reaction volume of 25 μL. The reaction was incubated at 37°C for 30 min in a heat-dried bath. The RPA amplicons were purified using a NucleoSpin gel and PCR clean-up kit (Macherey-Nagel GmbH & Co., Germany).

The purified RPA products (uniplex, duplex and triplex RPA) were detected using a single-stranded tag hybridization chromatographic printed-array strip (STH-PAS; TBA Co., Ltd., Japan). Briefly, 10 μL of 300 mM NaCl-modified dilution buffer and 1 μL of streptavidin-coated blue latex were added to 10 μL of the RPA product. The C-PAS4 membrane stick was dipped into the mixture for 5–10 min. The uniplex:duplex RPA products were evaluated at ratios (v/v) of 1:4, 2:4, 3:4 and 4:4. Each visible blue line indicated the presence of the respective ESBL target gene, which were from the bottom to top lines: blaCTX-M, blaSHV, and blaOXA (Fig 1).

Fig 1. Schematic illustration of the RPA-LFA for the detection of blaCTX-M, blaOXA, and blaSHV.

Fig 1

The C-PAS4 membrane strip has 3 position markers (red lines) and four imprinted tag oligonucleotides from the bottom to top lines (tag1-4; Left). The C-PAS4 membrane strip is inserted into a developing solution containing RPA amplicons (middle) for 5–10 min to allow the RPA amplicons to be trapped by the complementary tag sequences and generate visible blue lines (CTX, SHV, OXA) at the relevant positions, as indicated (right).

The specificity of the RPA-LFA was ascertained using E. coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, Acinetobacter baumannii ATCC 19606, Pseudomonas aeruginosa ATCC 27853, Proteus mirabilis ATCC 25933, Staphylococcus aureus ATCC 25923, and Enterococcus faecalis ATCC 29212. The limit of detection (LOD) for each ESBL gene was examined using various concentrations of each positive DNA template (0, 0.1, 1, 2.5, 5, 10, 50, and 100 ng/25 μL).

Detection of the blaCTX-M, blaOXA, and blaSHV genes in ESBL-producing E. coli by the RPA-LFA

All the ESBL-positive E. coli isolates from the pork, and cecum samples were screened for the presence of blaCTX-M, blaOXA, and blaSHV by the RPA-LFA. The TwistDx basic kit and STH-PAS dipstick were employed using the conditions determined in the present study.

Data analysis

The results of the RPA-LFA and PCR detection were compared, and the sensitivity and specificity of the RPA-LFA were analyzed using Medcalc® software (https://www.medcalc.org/calc/diagnostic_test.php). The level of agreement between the two diagnostic methods was evaluated for significance using kappa (κ) statistics with QuickCals software (https://www.graphpad.com/quickcalcs/kappa1) [28].

Results

Antimicrobial susceptibility patterns of E. coli isolated from retail pork meat and pig cecum samples

From the 100 pork samples individually collected from 100 retail markets, a single E. coli isolate was selected from 68 positive samples. Two and three isolates designated as E. coli with different biochemical results were selected from 9 and 4 samples, respectively. Thus, a total of 98 E. coli isolates were obtained from 81 pork samples. Of these screened E. coli isolates, 93.9% (92/98) were ESBL producers, and three isolates were resistant to carbapenem (Fig 2A).

Fig 2. Prevalence of ESBL-producing E. coli isolated from fresh pork meat and pig cecum samples and their antibiotic susceptibility profiles.

Fig 2

Numbers of (A, C) ESBL-producing E. coli and their (B, D) antibiotic-resistant profiles ascertained by disk diffusion, from (A, B) pork and (C, D) pig cecum samples. CRE; carbapenemase resistant Enterobacteriaceae.

From the fecal samples, a single E. coli isolate was selected from each of the 50 fecal samples collected from the slaughterhouse, and 96% (48/50) were ESBL producers (Fig 2C). Almost all the ESBL-producing isolates (92.14%) were found to display MDR, and they were resistant to at least one agent in three or more antimicrobial categories. The ESBL-MDR isolates remarkably resisted trimethoprim-sulfamethoxazole, gentamycin, tetracycline, and chloramphenicol (Fig 2B and 2D). Notably, a markedly higher percentage of ESBL-MDR isolates were found in the pig cecum samples (87.5–100%) than in the pork samples (45.6–88.0%).

Genotyping of ESBL-producing isolates

Among the total ESBL-positive-isolates, 91.3% (84/92) and 95.83% (46/48) carried blaCTX-M genes in the pork and cecum samples, respectively, either alone or in combination with blaTEM-1. Others isolates included blaSHV-12, TEM-1 (n = 1), blaSHV-12 (n = 1), blaTEM-1 (n = 7) and other ESBL gene/AMR mechanisms (n = 1). CTX-M group 9 type 55 was predominant (50%, 46/92) in the pork and pig cecum samples (66.7%, 32/48) (Fig 3). The blaCTX-M variants in the pork samples derived from the 100 individual markets were diverse and comprised 14 CTX-M types belonging to CTX-M groups 1 and 9 (CTX-M-1 group: CTX-M-15, CTX-M-55, CTX-M-79, and CTX-M-136; CTX-M-9 group: CTX-M-9, CTX-M-14, CTX-M-16, CTX-M-24, CTX-M-27, CTX-M-65, CTX-M-112, and CTX-M-161) and unclassified groups (CTX-M-176 and CTX-M-227). However, only four CTX-M types (CTX-M-55, CTX-M-14, CTX-M-15, and CTX-M-27) were observed in the cecum samples (Table 2).

Fig 3. Percentage of ESBL subtypes in ESBL-producing E. coli from pork (n = 92) and pig cecum samples (n = 48).

Fig 3

Table 2. Presence of the blaCTX-M, blaTEM, blaOXA, and blaSHV genes in ESBL-producing E. coli from fresh pork and cecum samples (n = 140).

Beta-lactamase genes in E. coli Fresh pork meat Pig cecum
No (%) No (%)
Total (n = 92) Total (n = 48)
CTX-M-55, TEM-1 28 (30.4) 23 (47.9)
CTX-M-55 15 (16.3) 9 (18.8)
CTX-M-55, TEM-30 1 (1.08) -
CTX-M-55, OXA-140 1 (1.08) -
CTX-M-55, TEM-176 1 (1.08) -
CTX-M-14 5 (5.43) 2 (4.16)
CTX-M-14, TEM-1 5 (5.43) 3 (6.25)
CTX-M-15 3 (3.24) -
CTX-M-15, TEM-1 4 (4.32) 1 (2.08)
CTX-M-15, OXA-1 1 (1.08) -
CTX-M-9 3 (3.24) -
CTX-M-9, TEM-1 1 (1.08) -
CTX-M-9, TEM-176 1 (1.08) -
CTX-M-27 2 (2.16) 1 (2.08)
CTX-M-27, TEM-1 2 (2.16) 7 (14.6)
CTX-M-227 1 (1.08) -
CTX-M-227, TEM-1 2 (2.16) -
CTX-M-16, TEM-1 1 (1.08) -
CTX-M-24 1 (1.08) -
CTX-M-65 1 (1.08) -
CTX-M-79 1 (1.08) -
CTX-M-112 1 (1.08) -
CTX-M-136 1 (1.08) -
CTX-M-161, TEM-1 1 (1.08) -
CTX-M-176 1 (1.08) -
SHV-12 - 1 (2.08)
SHV-12, TEM-1 1 (1.08) -
TEM-1 6 (6.52) 1 (2.08)
Other ESBL genes/AMR mechanisms 1 (1.08) -

Optimization of the RPA-LFA for the detection of blaCTX-M, blaOXA, and blaSHV

The uniplex RPA-LFA successfully amplified blaCTX-M, blaOXA, and blaSHV, each of which showed a visible blue line at the designated position on the dipstick strip (an example of blaSHV is shown in Fig 4A, no. 1 and 2). However, the multiplex RPA-LFA with all three primer sets resulted in a false-positive line for the blaSHV gene in the no DNA template negative control (Fig 4A, no. 5 and 6). The duplex blaCTX-M and blaOXA primers yielded positive results at the designated lines (Fig 4A, no. 3 and 4) with no cross-reactivity in the negative control. The optimum RPA-LFA condition for blaCTX-M, blaOXA, and blaSHV detection (Fig 4B) was determined by mixing the uniplex RPA product of blaSHV with the duplex RPA products of blaCTX-M and blaOXA at a 2:4 (v/v) ratio before LFA detection. The blaTEM gene was not detectable by RPA due to blaTEM contamination in the engineered recombinase enzyme in the TwistDx kit, which originated from blaTEM-1-containing E. coli K-12 and resulted in a false positive TEM result [29, 30].

Fig 4. Detection of the blaCTX-M, blaOXA, and blaSHV genes by the RPA-LFA.

Fig 4

A visible blue line represents a positive detection. Detection of uniplex (no.1 and 2), duplex (no. 3 and 4), and triplex bla genes (no. 5 and 6) from the three bla genes (A). The combination of the uniplex blaSHV product with the duplex blaCTX-M and blaOXA products at 1:4, 2:4, 3:4 and 4:4 (v/v) ratios (B). C+; positive DNA control, C-; no template control.

Specificity of the RPA-LFA for the detection of blaCTX-M, blaOXA, and blaSHV

As shown in Fig 5, K. pneumoniae ATCC 700603, carrying the blaSHV gene, and the three ESBL-positive DNA templates (blaCTX-M, blaOXA, and blaSHV) showed positive lines at their respective positions on the strip. No cross-reaction was detected among the blaCTX-M, blaOXA, and blaSHV genes in E. coli ATCC 25922, K. pneumoniae ATCC 700603, A. baumannii ATCC 19606, P. aeruginosa ATCC 27853, P. mirabilis ATCC 25933, S. aureus ATCC 25923, and E. faecalis ATCC 29212.

Fig 5. Specificity of the RPA-LFA for blaCTX-M, blaOXA, and blaSHV.

Fig 5

C+, positive DNA control; C-, no template control.

LOD of the RPA-LFA blaCTX-M, blaOXA, and blaSHV

To measure the sensitivity of the RPA-LFA for ESBL gene detection, the blaCTX-M, blaOXA, and blaSHV DNA templates were screened at 0, 0.1, 2.5, 5, 10, 50, and 100 ng/25 μL. Positive results were determined as obvious blue lines. The LOD for all three genes was found to be 2.5 ng/25 μL (Fig 6).

Fig 6. LODs for blaCTX-M, blaOXA, and blaSHV detection of the RPA-LFA.

Fig 6

The LODs for blaCTX-M, blaOXA, and blaSHV of the RPA-LFA method were determined using various concentrations (0, 0.1, 2.5, 5, 10, 50 and 100 ng/25 μL) of the respective DNA template. C-, no template control.

Comparison of the RPA-LFA and PCR for the detection of the blaCTX-M, blaOXA, and blaSHV genes

To examine the efficiency of the RPA-LFA, a total of 140 ESBL-producing E. coli isolates (92 ESBL-positive pork isolates and 48 ESBL-positive fecal isolates) were tested by the RPA-LFA developed in the present study, and the results were compared to the results obtained by screening the same isolates by diagnostic PCR. Of 130 blaCTX-M PCR-positive samples, a discrepancy was revealed in one of the blaCTX-M, blaTEM samples by RPA-LFA (Table 3). According to agreement analysis, both methods showed completely matched results, with 129 positive and 10 negative blaCTX-M samples and two positive and 138 negative blaSHV and blaOXA samples, except one false-positive result (compared to the PCR) detected for blaCTX-M by the RPA-LFA (Tables 3 and 4). The otherwise concordant results of both methods provided almost perfect agreement (k = 0.949 for blaCTX-M and k = 1.000 for both blaSHV and blaOXA). The sensitivity of the RPA-LFA for blaCTX-M and both blaSHV and blaOXA detection were 99.2% (95% confidence interval [CI] = 95.8–100%) and 100% (95% CI = 15.8–100%), respectively. The specificity of the RPA-LFA for blaCTX-M and both blaSHV and blaOXA detection were 100% (95% CI = 69.2–100%) and 100% (95% CI = 97.4–100%), respectively.

Table 3. Pairwise comparison between RPA-LFA and PCR detection of blaCTX-M, blaOXA, and blaSHV (n = 140).

Beta lactamase genes PCR RPA-LFA
blaCTX-M blaOXA blaSHV
blaCTX-M 130 129 2 0
blaCTX-M alone 47 47 0 0
blaCTX-M, blaTEM 81 80 0 0
blaCTX-M, blaOXA 2 2 2 0
blaSHV 2 0 0 2
blaSHV alone 1 0 0 1
blaSHV, blaTEM 1 0 0 1
blaTEM
blaTEM alone 7 0 0 0
Other ESBL genes/AMR mechanisms 1 0 0 0

Table 4. Agreement analysis between RPA-LFA and PCR detection of blaCTX-M, blaOXA, and blaSHV (n = 140).

PCR
RPA-LFA CTX-M+ CTX-M- Totals OXA+ OXA- Totals SHV+ SHV- Totals
CTX-M+ 129 1 130 OXA+ 2 0 2 SHV+ 2 0 2
CTX-M- 0 10 10 OXA- 0 138 138 SHV- 0 138 138
Totals 129 11 140 2 138 140 2 138 140
Positive agreement: 99% CI 95% [95.8%-100%] Positive agreement: 100% CI 95% [15.8%-100%] Positive agreement: 100% CI 95% [15.8%-100%]
Negative agreement: 100% CI 95% [69.2%-100%] Negative agreement: 100% CI 95% [97.4%-100%] Negative agreement: 100% CI 95% [97.4%-100%]

Discussion

Due to some of the limitations of phenotypic detection methods and the nonportability, expense, and technical skill required for the available advanced genotypic assays, the development of a more rapid and equipment-free system for the detection of ESBL genes is required. The aim of this study was to develop a rapid and simple diagnostic test for the most common ESBL genes encoding CTX-M, OXA, and SHV using an RPA-LFA method. The developed RPA could rapidly amplify blaCTX-M, blaOXA, and blaSHV at 37°C in 30 min with easily interpreted visual results by the naked eye on lateral flow strips. Although, our RPA-LFA utilized two separate duplex (blaCTX-M, blaOXA) and uniplex (blaSHV) RPA reactions, the amplification was simple and rapid with no need for an expensive thermal cycler. Moreover, there is no need for gel preparation and staining, which shortens the detection time and decreases the amount of cumbersome processing. Multiplex isothermal amplifications are different among different strategies. Detection by multiplex loop-mediated isothermal amplification is difficult to perform because of the complicated structure of the primers and the recommended amplicon size of < 250 bp. Only a few multiplex helicase-dependent amplifications have been reported because the short amplicon size of < 150 bp is a limitation. Likewise, strand displacement amplification requires at least four primers/target and restriction enzyme digestion, which obstructs multiplexing [31]. The benefits of RPA are its low operating temperature (37–42°C), which is compatible with general heating instruments in the laboratory or even body temperature; its lack of requirement for tight temperature control and initial denaturation; and its rapid amplification time of within 5–25 min. The recombinase typically consumes all the available ATP within 25 min [32]. Although, our multiplex RPA primers were shorter (20–26 bp) than the recommended length of 30–35 bp, amplification of the blaCTX-M, blaOXA, and blaSHV genes was still accomplished and generated the product sizes from 296–593 bp. Longer primers with higher GC contents increase the probability of primer-dimer formation, while the optimal RPA amplicon size ranges from 100–200 bp. Longer products require a longer amplification time as well as an optimum ratio and concentration of primers [32].

Duplex and uniplex RPA products combined at a 2:4 (v/v) ratio provided specific detection of the three target genes on a lateral flow strip. Obvious blue lines for the specific RPA products corresponding to the blaCTX-M, blaSHV, and blaOXA genes appeared within 10 min. A false SHV result was demonstrated in the triplex RPA-LFA, which might have been due to the biotin primers self-pairing with the blaSHV-tag primers and subsequently hybridizing with the immobilized complementary oligonucleotides on the strip. The LOD was 2.5 ng/25 μL with no cross-reaction against seven common human pathogens. The LOD of the RPA-LFA depends on several factors, including the amplification efficiency, the multiplex level of each primer, self-pairing among primers, and the different (biased) amplification efficiencies of the different primers. Primer design and extensive optimization of multiplex nucleic acid amplification incorporated with LFA assays are critical steps to avoid primer dimers and nonspecific results [31]. The coupling of powerful amplification methods with simple detection platforms, especially lateral flow strips, increases the feasibility of their application in point of care or field detection [33]. Of the various LFA formats, the STH-PAS is a lateral flow dipstick format that allows the detection of multiple targets in a single reaction and easy visualization of the results in a short time by the naked eye. The optimum condition for STH-PAS detection depends on the stringency of the developing buffer, the ratio of products to developing buffer, and incubation time. For isothermal amplification, the reagent’s instructions recommend using a modified dilution buffer and diluting the template five- to tenfold with TE buffer or water (TBA Co., Ltd.).

The sensitivity and specificity of our RPA-LFA for the detection all three common ESBL genes in pork and pig cecum samples were 99.2–100% and in almost perfect agreement (κ = 0.949–1.00) with the PCR results. Multiplex PCR combined with STH-PAS has shown high sensitivity (93.3%) and specificity (99.1%) for the direct detection of carbapenemase genes from stool specimens within 2 h [34, 35]. The transmission of the mcr-1 gene and carbapenem-resistant Enterobacteriaceae has been determined using a PCR-STH-PAS dipstick and pulse-field gel electrophoresis [35]. However, no multiplex RPA combined with STH-PAS has been reported before. A combination of other common drug resistance genes, including blaTEM, plasmid-mediated AmpC beta lactamase genes, carbapenemase genes, and internal control lines, in one strip remains a challenge.

Overall, E. coli was found in 81% of the pork samples obtained from 100 retail markets in Bangkok, Thailand. This high level of contamination with E. coli is not only an indicator of poor hygiene but also indicates the distribution of antibiotic resistance in foods. Out of 98 E. coli isolates from pork that were tested, 93.9% were ESBL positive, and three isolates with carbapenem resistance were observed. Similarly, intestinal carriage of ESBL-positive E. coli in pigs was 96% in the tested slaughterhouse, which provides wholesale pork products throughout fresh markets in Bangkok and nearby provinces. High MDR profiles existed mostly in ESBL-positive E. coli, which implies a crisis in antibiotic usage. ESBL genes are located on plasmids, which are usually coexpressed with other plasmid-mediated drug resistance genes, such as quinolone, aminoglycosides, trimethoprim, and tetracyclines [36, 37]. Similar to a previous report, a high incidence of ESBLs with resistance to other drug classes was observed among food animals and fresh meats in Thailand [11, 38]. The presence of ESBL-MDR pathogens is a serious health problem due to the limited available drug regimens for treatment. Food producers, including farms and slaughterhouses, are important transmission sources of antibiotic resistance [39, 40].

The frequency of CTX-M was high in both pork (91.3%) and pig cecum samples (95.8%), with the majority being CTX-M-55. Only four subtypes (CTX-M-55, CTX-M-14, CTX-M-15, and CTX-M-27) were detected in the pig fecal samples from the slaughterhouse, while 14 CTX-M subtypes were detected in raw pork samples from shops that came from various slaughterhouses. A high prevalence of CTX-M-55 in pork has been reported previously in many countries, including Cambodia, Hong Kong, and Vietnam [4143]. A total of 212 ESBL-producing E. coli isolated from healthy subjects in the community and swine of Lamphun Province, Thailand, revealed that 95.8% were positive for CTX-M, with the most common subtype being CTX-M-55, followed by TEM (60.9%) and SHV (2.4%) [44]. The emergence of CTX-M-55 has also been observed in Salmonella isolates from raw meat and food animals in China and Cambodia [42, 45]. However, the prevalence of ESBL subtypes varies in each geographical and epidemiological area. Antibiotic management is required in the whole production system, from farms to consumers. Moreover, the consumption of cooked meats is safer from food spoilage organisms and has a lower risk of antibiotic transmission than raw foods.

Conclusion

The RPA-LFA (using STH-PAS) is a rapid and reliable tool for the detection of ESBL-producing E. coli in pork and fecal samples. RPA amplification can be performed using simple heating equipment, and the results can be easily examined by the naked eye on a lateral flow strip. Thus, the assay is convenient for ESBL detection in food animals, patients, and environmental samples in low-resource settings.

Data Availability

All relevant data are within the paper.

Funding Statement

This research project was granted by Agricultural Research Development Agency (Public Organization) or “ARDA” and partially supported by Research Unit of Innovative Diagnosis of Antimicrobial Resistance, Ratchadapisek Sompoch Endowment fund and the Second Century Fund (C2F), Chulalongkorn University and Japan Agency for Medical Research and Development (AMED). We would like to extend our sincerest gratitude to Graduate School as well as Faculty of Allied Health Sciences at Chulalongkorn University for providing the Overseas Research Experience Scholarship for Graduate Students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Landers TF, Cohen B, Wittum TE, Larson EL. A Review of Antibiotic Use in Food Animals: Perspective, Policy, and Potential. 2012;127(1):4–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Geser N, Stephan R, Hächler H. Occurrence and characteristics of extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae in food producing animals, minced meat and raw milk. BMC veterinary research. 2012;8:21. 10.1186/1746-6148-8-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lima CM, Souza IEGL, Alves TD, Leite CC, Evangelista-Barreto NS, Almeida RCD. Antimicrobial resistance in diarrheagenic Escherichia coli from ready-to-eat foods. J Food Sci Tech Mys. 2017;54(11):3612–9. 10.1007/s13197-017-2820-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rasheed MU, Thajuddin N, Ahamed P, Teklemariam Z, Jamil K. Antimicrobial drug resistance in strains of Escherichia coli isolated from food sources. Rev Inst Med Trop Sao Paulo. 2014;56(4):341–6. 10.1590/s0036-46652014000400012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dohmen W, Bonten MJ, Bos ME, van Marm S, Scharringa J, Wagenaar JA, et al. Carriage of extended-spectrum β-lactamases in pig farmers is associated with occurrence in pigs. Clin Microbiol Infect. 2015;21(10):917–23. 10.1016/j.cmi.2015.05.032 [DOI] [PubMed] [Google Scholar]
  • 6.Dohmen W, Dorado-Garcia A, Bonten MJ, Wagenaar JA, Mevius D, Heederik DJ. Risk factors for ESBL-producing Escherichia coli on pig farms: A longitudinal study in the context of reduced use of antimicrobials. PLoS One. 2017;12(3):e0174094. 10.1371/journal.pone.0174094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Tacconelli E, Magrini N. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics WHO Essential medicines and health products. Available from: https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/
  • 8.Saliu EM, Vahjen W, Zentek J. Types and prevalence of extended-spectrum beta-lactamase producing Enterobacteriaceae in poultry. Anim Health Res Rev. 2017;18(1):46–57. 10.1017/S1466252317000020 [DOI] [PubMed] [Google Scholar]
  • 9.Hu YJ, Ogyu A, Cowling BJ, Fukuda K, Pang HH. Available evidence of antibiotic resistance from extended-spectrum β-lactamase-producing Enterobacteriaceae in paediatric patients in 20 countries: a systematic review and meta-analysis. Bull World Health Organ. 2019;97(7):486–501b. 10.2471/BLT.18.225698 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657–86. 10.1128/CMR.18.4.657-686.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Boonyasiri A, Tangkoskul T, Seenama C, Saiyarin J, Tiengrim S, Thamlikitkul V. Prevalence of antibiotic resistant bacteria in healthy adults, foods, food animals, and the environment in selected areas in Thailand. Pathog Glob Health. 2014;108(5):235–45. 10.1179/2047773214Y.0000000148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gundran RS, Cardenio PA, Salvador RT, Sison FB, Benigno CC, Kreausukon K, et al. Prevalence, Antibiogram, and Resistance Profile of Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Pig Farms in Luzon, Philippines. Microb Drug Resist. 2020;26(2):160–8. 10.1089/mdr.2019.0019 [DOI] [PubMed] [Google Scholar]
  • 13.Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms. Clin Infect Dis. 2000;30(5):799–808. 10.1086/313788 [DOI] [PubMed] [Google Scholar]
  • 14.Su M, Satola SW, Read TD. Genome-Based Prediction of Bacterial Antibiotic Resistance. J Clin Microbiol. 2019;57(3). 10.1128/JCM.01405-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Peker N, Rossen JWA, Deurenberg RH, Langereis PC, Raangs EGC, Kluytmans JA, et al. Evaluation of an Accelerated Workflow for Surveillance of ESBL (CTX-M)-Producing Escherichia coli Using Amplicon-Based Next-Generation Sequencing and Automated Analysis. Microorganisms. 2018;6(1). 10.3390/microorganisms6010006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhang J, Zheng B, Zhao L, Wei Z, Ji J, Li L, et al. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals. BMC infectious diseases. 2014;14:659. 10.1186/s12879-014-0659-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lascols C, Hackel M, Hujer AM, Marshall SH, Bouchillon SK, Hoban DJ, et al. Using nucleic acid microarrays to perform molecular epidemiology and detect novel β-lactamases: a snapshot of extended-spectrum β-lactamases throughout the world. J Clin Microbiol. 2012;50(5):1632–9. 10.1128/JCM.06115-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Daher RK, Stewart G, Boissinot M, Bergeron MG. Recombinase Polymerase Amplification for Diagnostic Applications. Clin Chem. 2016;62(7):947–58. 10.1373/clinchem.2015.245829 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ghosh DK, Kokane SB, Kokane AD, Warghane AJ, Motghare MR, Bhose S, et al. Development of a recombinase polymerase based isothermal amplification combined with lateral flow assay (HLB-RPA-LFA) for rapid detection of "Candidatus Liberibacter asiaticus". PLOS ONE. 2018;13(12):e0208530. 10.1371/journal.pone.0208530 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Singpanomchai N, Akeda Y, Tomono K, Tamaru A, Santanirand P, Ratthawongjirakul P. Naked eye detection of the Mycobacterium tuberculosis complex by recombinase polymerase amplification-SYBR green I assays. J Clin Lab Anal. 2019;33(2):e22655. 10.1002/jcla.22655 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Heeroma AJ, Gwenin C. Development of Solid-Phase RPA on a Lateral Flow Device for the Detection of Pathogens Related to Sepsis. Sensors. 2020;20(15). 10.3390/s20154182 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bergey DH, Holt JH. Bergey’s manual of determinative bacteriology. 9th ed. Baltimore: Williams &Wilkins; 1994. [Google Scholar]
  • 23.Hasman H, Mevius D, Veldman K, Olesen I, Aarestrup FM. beta-Lactamases among extended-spectrum beta-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J Antimicrob Chemother. 2005;56(1):115–21. 10.1093/jac/dki190 [DOI] [PubMed] [Google Scholar]
  • 24.Sturenburg E, Lang M, Horstkotte MA, Laufs R, Mack D. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria. J Antimicrob Chemother. 2004;54(5):870–5. 10.1093/jac/dkh449 [DOI] [PubMed] [Google Scholar]
  • 25.Kim J, Kwon Y, Pai H, Kim JW, Cho DT. Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J Clin Microbiol. 1998;36(5):1446–9. 10.1128/JCM.36.5.1446-1449.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Costa D, Poeta P, Saenz Y, Vinue L, Rojo-Bezares B, Jouini A, et al. Detection of Escherichia coli harbouring extended-spectrum beta-lactamases of the CTX-M, TEM and SHV classes in faecal samples of wild animals in Portugal. J Antimicrob Chemother. 2006;58(6):1311–2. 10.1093/jac/dkl415 [DOI] [PubMed] [Google Scholar]
  • 27.Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 29th ed. Wayne, PA; 2019. [Google Scholar]
  • 28.Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74. [PubMed] [Google Scholar]
  • 29.Piepenburg O, Williams CH, Stemple DL, Armes NA. DNA detection using recombination proteins. PLOS Biology. 2006;4(7):e204. 10.1371/journal.pbio.0040204 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Yano H, Kuga A, Okamoto R, Kitasato H, Kobayashi T, Inoue M. Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother. 2001;45(5):1343–8. 10.1128/AAC.45.5.1343-1348.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lin WH, Zou BJ, Song QX, Zhou GH. Progress in multiplex loop-mediated isothermal amplification technology. Yi Chuan. 2015;37(9):899–910. 10.16288/j.yczz.15-141 [DOI] [PubMed] [Google Scholar]
  • 32.Mayboroda O, Katakis I, O’Sullivan CK. Multiplexed isothermal nucleic acid amplification. Anal Biochem. 2018;545:20–30. 10.1016/j.ab.2018.01.005 [DOI] [PubMed] [Google Scholar]
  • 33.Luo K, Kim HY, Oh MH, Kim YR. Paper-based lateral flow strip assay for the detection of foodborne pathogens: principles, applications, technological challenges and opportunities. Crit Rev Food Sci Nutr. 2020;60(1):157–70. 10.1080/10408398.2018.1516623 [DOI] [PubMed] [Google Scholar]
  • 34.Shanmugakani RK, Akeda Y, Yamamoto N, Sakamoto N, Hagiya H, Yoshida H, et al. PCR-Dipstick Chromatography for Differential Detection of Carbapenemase Genes Directly in Stool Specimens. Antimicrob Agents Chemother. 2017;61(6). 10.1128/AAC.00067-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Shanmugakani RK, Akeda Y, Sugawara Y, Laolerd W, Chaihongsa N, Sirichot S, et al. PCR-Dipstick-Oriented Surveillance and Characterization of mcr-1- and Carbapenemase-Carrying Enterobacteriaceae in a Thai Hospital. Front Microbiol. 2019;10:149. 10.3389/fmicb.2019.00149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Liu X, Thungrat K, Boothe DM. Occurrence of OXA-48 Carbapenemase and Other β-Lactamase Genes in ESBL-Producing Multidrug Resistant Escherichia coli from Dogs and Cats in the United States, 2009–2013. Front Microbiol. 2016;7:1057. 10.3389/fmicb.2016.01057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mohsin M, Raza S, Schaufler K, Roschanski N, Sarwar F, Semmler T, et al. High Prevalence of CTX-M-15-Type ESBL-Producing E. coli from Migratory Avian Species in Pakistan. Front Microbiol. 2017;8:2476. 10.3389/fmicb.2017.02476 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Trongjit S, Angkittitrakul S, Chuanchuen R. Occurrence and molecular characteristics of antimicrobial resistance of Escherichia coli from broilers, pigs and meat products in Thailand and Cambodia provinces. Microbiol Immunol. 2016;60(9):575–85. 10.1111/1348-0421.12407 [DOI] [PubMed] [Google Scholar]
  • 39.Aguirre L, Vidal A, Seminati C, Tello M, Redondo N, Darwich L, et al. Antimicrobial resistance profile and prevalence of extended-spectrum beta-lactamases (ESBL), AmpC beta-lactamases and colistin resistance (mcr) genes in Escherichia coli from swine between 1999 and 2018. Porcine Health Manag. 2020;6:8. 10.1186/s40813-020-00146-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Paivarinta M, Latvio S, Fredriksson-Ahomaa M, Heikinheimo A. Whole genome sequence analysis of antimicrobial resistance genes, multilocus sequence types and plasmid sequences in ESBL/AmpC Escherichia coli isolated from broiler caecum and meat. Int J Food Microbiol. 2020;315:108361. 10.1016/j.ijfoodmicro.2019.108361 [DOI] [PubMed] [Google Scholar]
  • 41.Sapugahawatte DN, Li C, Zhu C, Dharmaratne P, Wong KT, Lo N, et al. Prevalence and Characteristics of Extended-Spectrum-beta-Lactamase-Producing and Carbapenemase-Producing Enterobacteriaceae from Freshwater Fish and Pork in Wet Markets of Hong Kong. mSphere. 2020;5(2). 10.1128/mSphere.00107-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Nadimpalli M, Fabre L, Yith V, Sem N, Gouali M, Delarocque-Astagneau E, et al. CTX-M-55-type ESBL-producing Salmonella enterica are emerging among retail meats in Phnom Penh, Cambodia. J Antimicrob Chemother. 2019;74(2):342–8. 10.1093/jac/dky451 [DOI] [PubMed] [Google Scholar]
  • 43.Nguyen DT, Kanki M, Nguyen PD, Le HT, Ngo PT, Tran DN, et al. Prevalence, antibiotic resistance, and extended-spectrum and AmpC beta-lactamase productivity of Salmonella isolates from raw meat and seafood samples in Ho Chi Minh City, Vietnam. Int J Food Microbiol. 2016;236:115–22. 10.1016/j.ijfoodmicro.2016.07.017 [DOI] [PubMed] [Google Scholar]
  • 44.Seenama C, Thamlikitkul V, Ratthawongjirakul P. Multilocus sequence typing and bla ESBL characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolated from healthy humans and swine in Northern Thailand. Infect Drug Resist. 2019;12:2201–14. 10.2147/IDR.S209545 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Zhang CZ, Ding XM, Lin XL, Sun RY, Lu YW, Cai RM, et al. The Emergence of Chromosomally Located bla CTX-M-55 in Salmonella From Foodborne Animals in China. Front Microbiol. 2019;10:1268. 10.3389/fmicb.2019.01268 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Iddya Karunasagar

10 Feb 2021

PONE-D-20-40583

Rapid detection of extended spectrum β-lactamase producing Escherichia coli isolated from fresh pork meat and pig caecum samples using multiplex recombinase polymerase amplification and lateral flow strip analysis

PLOS ONE

Dear Dr. Chaichanawongsaroj,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please correct discrepancy in Table 3.

Please submit your revised manuscript by Mar 25 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Iddya Karunasagar

Academic Editor

PLOS ONE

Additional Editor Comments:

In addition to what the reviewer has pointed out, it is noted than in Table 3, it is stated that n=140. Column 2 shows that 130 were PCR positive for blaCTX-M and column 3 shows the breakup of different combinations - either blaCTX-M alone or along with blaOXA and blaTEM and the total is 129. It should be 130 as per column 2. Why this discrepancy?

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Manuscript no: PONE-D-20-40583 Manuscript title: Rapid detection of extended spectrum β-lactamase producing Escherichia coli isolated from fresh pork meat and pig caecum samples using multiplex recombinase polymerase amplification and lateral flow strip analysis

This manuscript describes development of multiplex RPA combined with LFA to detect the three most common ESBL genes (blaCTX-M, blaOXA, and blaSHV) and looked into their sensitivities and specificities. The assay developed in this study is convenient for ESBL detection in food animals, patients, and environmental samples in low resource settings. In this regard, the data presented in this manuscript is informative. I feel that this manuscript is worthy of publication in PLOS ONE after revision.

Following are the comments:

1. I would recommend the manuscript to be edited by native speaker of English prior to re-submission.

2. Fig 1. Spelling of “solution” need to be corrected

3. Pictures are not very clear. Could these photographs be improved at all?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Praveen Rai

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 15;16(3):e0248536. doi: 10.1371/journal.pone.0248536.r002

Author response to Decision Letter 0


25 Feb 2021

Dear Editor-in-Chief,

We thank reviewers for constructive comments. We have revised our manuscript and the followings are responses to comments of reviewers.

Response to Editor Comments:

• Please correct discrepancy in Table 3. It is noted than in Table 3, it is stated that n=140. Column 2 shows that 130 were PCR positive for blaCTX-M and column 3 shows the breakup of different combinations - either blaCTX-M alone or along with blaOXA and blaTEM and the total is 129. It should be 130 as per column 2. Why this discrepancy?

Response: The discrepancy in Table 3 is correct. The total number of blaCTX-M detected by PCR was 130, while RPA-LFA demonstrated only 129 of blaCTX-M. One PCR positive sample of blaCTX-M and blaTEM gave false negative by RPA-LFA.

The clarification was incorporated in page 15, line 6-8: Of 130 blaCTX-M PCR-positive samples, a discrepancy was revealed in one of the blaCTX-M, blaTEM samples by RPA-LFA (Table 3).

Addition correction has been done in Table 3, the number of blaCTM-M alone and blaCTX-M, blaTEM detected by RPA-LFA were 47 and 80, respectively.

Response to Reviewer #1:

1. I would recommend the manuscript to be edited by native speaker of English prior to re-submission.

Response: The revised manuscript has already English proof by AJE before re-submission. The corrections have been done as in “Manuscript with track changes”.

2. Fig 1. Spelling of “solution” need to be corrected

Response: This typing error “solution” in Fig.1 has already corrected.

3. Pictures are not very clear. Could these photographs be improved at all?

Response: This concern of photographs has already improved and check by Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool to ensure that figures meet PLOS requirements.

Additional correction.

1. The revised manuscript has been rechecked and edited to meets PLOS ONE’s style requirements.

2. The detail of figure legend in Fig 1. has been incorporated in page8, line 17-21: “The C-PAS4 membrane strip has 3 position markers (red lines) and four imprinted tag oligonucleotides from the bottom to top lines (tag1-4; Left). The C-PAS4 membrane strip is inserted into a developing solution containing RPA amplicons (middle) for 5-10 min to allow the RPA amplicons to be trapped by the complementary tag sequences and generate visible blue lines (CTX, SHV, OXA) at the relevant positions, as indicated (right). ”.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Iddya Karunasagar

1 Mar 2021

Rapid detection of extended spectrum β-lactamase producing Escherichia coli isolated from fresh pork meat and pig cecum samples using multiplex recombinase polymerase amplification and lateral flow strip analysis

PONE-D-20-40583R1

Dear Dr. Chaichanawongsaroj,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Iddya Karunasagar

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

All reviewer comments have been addressed,

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Authors have satisfactorily response the comments of this reviewer.

Minor correction required in table 1: primer tag need to be changed from "3' " to "5'" end of the primers.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Iddya Karunasagar

4 Mar 2021

PONE-D-20-40583R1

Rapid detection of extended spectrum β-lactamase producing Escherichia coli isolated from fresh pork meat and pig cecum samples using multiplex recombinase polymerase amplification and lateral flow strip analysis 

Dear Dr. Chaichanawongsaroj:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Iddya Karunasagar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES